| The global burden of hepatitis E virus genotypes 1 and 2 in 2005 DB Rein, GA Stevens, J Theaker, JS Wittenborn, ST Wiersma Hepatology 55 (4), 988-997, 2012 | 900 | 2012 |
| The economic burden of major adult visual disorders in the United States DB Rein, P Zhang, KE Wirth, PP Lee, TJ Hoerger, N McCall, R Klein, ... Archives of ophthalmology 124 (12), 1754-1760, 2006 | 777 | 2006 |
| Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments DB Rein, JS Wittenborn, X Zhang, AA Honeycutt, SB Lesesne, J Saaddine, ... Archives of ophthalmology 127 (4), 533-540, 2009 | 432 | 2009 |
| The cost-effectiveness of birth-cohort screening for hepatitis C antibody in US primary care settings DB Rein, BD Smith, JS Wittenborn, SB Lesesne, LD Wagner, DW Roblin, ... Annals of internal medicine 156 (4), 263-270, 2012 | 397 | 2012 |
| Direct medical cost of pelvic inflammatory disease and its sequelae: decreasing, but still substantial DB Rein, WJ Kassler, KL Irwin, L Rabiee Obstetrics & Gynecology 95 (3), 397-402, 2000 | 279 | 2000 |
| Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States DB Rein, JS Wittenborn, CM Weinbaum, M Sabin, BD Smith, SB Lesesne Digestive and Liver Disease 43 (1), 66-72, 2011 | 262 | 2011 |
| The cost-effectiveness, health benefits, and financial costs of new antiviral treatments for hepatitis C virus DB Rein, JS Wittenborn, BD Smith, DK Liffmann, JW Ward Clinical infectious diseases 61 (2), 157-168, 2015 | 181 | 2015 |
| The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States DB Rein, JS Wittenborn, PP Lee, KE Wirth, SW Sorensen, TJ Hoerger, ... Ophthalmology 116 (5), 823-832, 2009 | 104 | 2009 |
| Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States DB Rein, KA Hicks, KE Wirth, K Billah, L Finelli, AE Fiore, TJ Hoerger, ... Pediatrics 119 (1), e12-e21, 2007 | 95 | 2007 |
| Prevalence of age-related macular degeneration in the US in 2019 DB Rein, JS Wittenborn, Z Burke-Conte, R Gulia, T Robalik, JR Ehrlich, ... JAMA ophthalmology 140 (12), 1202-1208, 2022 | 89 | 2022 |
| Prevalence of visual acuity loss or blindness in the US: a Bayesian meta-analysis AD Flaxman, JS Wittenborn, T Robalik, R Gulia, RB Gerzoff, EA Lundeen, ... JAMA ophthalmology 139 (7), 717-723, 2021 | 83 | 2021 |
| Cost of vision problems: the economic burden of vision loss and eye disorders in the United States J Wittenborn, D Rein Ophthalmology 60603, 2013 | 83 | 2013 |
| The cost‐effectiveness of three screening alternatives for people with diabetes with no or early diabetic retinopathy DB Rein, JS Wittenborn, X Zhang, BA Allaire, MS Song, R Klein, ... Health services research 46 (5), 1534-1561, 2011 | 77 | 2011 |
| The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity GL Armstrong, K Billah, DB Rein, KA Hicks, KE Wirth, BP Bell Pediatrics 119 (1), e22-e29, 2007 | 72 | 2007 |
| The economic costs and benefits of dog guides for the blind KE Wirth, DB Rein Ophthalmic Epidemiology 15 (2), 92-98, 2008 | 68 | 2008 |
| The economic burden of vision loss and blindness in the United States DB Rein, JS Wittenborn, P Zhang, F Sublett, PA Lamuda, EA Lundeen, ... Ophthalmology 129 (4), 369-378, 2022 | 58 | 2022 |
| Cost-effectiveness of glaucoma interventions in Barbados and Ghana JS Wittenborn, DB Rein Optometry and Vision Science 88 (1), 155-163, 2011 | 57 | 2011 |
| Cost-effectiveness of vitamin therapy for age-related macular degeneration DB Rein, JB Saaddine, JS Wittenborn, KE Wirth, TJ Hoerger, ... Ophthalmology 114 (7), 1319-1326, 2007 | 57 | 2007 |
| New HIV cases attributable to syphilis in the USA: estimates from a simplified transmission model HW Chesson, SD Pinkerton, KL Irwin, D Rein, WJ Kassler Aids 13 (11), 1387-1396, 1999 | 56 | 1999 |
| The cost of visual impairment: purposes, perspectives, and guidance KD Frick, SM Kymes, PP Lee, DB Matchar, ML Pezzullo, DB Rein, ... Investigative ophthalmology & visual science 51 (4), 1801-1805, 2010 | 55 | 2010 |
Amanda A HoneycuttSenior Economist, Centers for Disease Control and Prevention在 cdc.gov 的电子邮件经过验证
Amanda A HoneycuttSenior Economist, Centers for Disease Control and Prevention在 cdc.gov 的电子邮件经过验证